29/02/2024 |
Quality of life and safety of CARMINAL® nutritional supplement in patients with mild or moderate ulcerative colitis |
CATALYSIS |
Registered |
07/03/2024 |
Quality of Life and safety of the nutritional supplement Deprexil® or Placebo in combination with cognitive stimulation treatment in patients with Mild Cognitive Impairment and Mild Alzheimer's Dementia. |
CATALYSIS |
Registered |
2008-09-12 |
Tisuacryl® in Dentistry |
BIOMAT |
Registered |
2008-09-12 |
Tisuacryl® in esophageal surgery |
BIOMAT |
Registered |
2008-09-30 |
Cutaneous Use of Tisuacryl® |
BIOMAT |
Registered |
2008-09-18 |
Tisuacryl® in Dental Hyperesthesia |
BIOMAT |
Registered |
11/03/2016 |
Biograft-G in Dentistry |
BIOMAT |
Registered |
2012-04-02 |
Sublingual immunotherapy with VALERGEN-Asthma-Children-Phase II |
BIOCEN |
Registered |
2012-04-13 |
Combined Subcutaneous immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |
BIOCEN |
Registered |
2013-01-04 |
Subcutaneous immunotherapy with PROLINEM -Asthma- Adults-Fase I |
BIOCEN |
Registered |
2010-12-07 |
Efficacy of VALERGENT-BT subcutaneous vaccine in asthmatic adults |
BIOCEN |
Registered |
2010-12-07 |
Efficacy of VALERGEN-DP subcutaneous vaccine in asthmatic adults |
BIOCEN |
Registered |
2010-12-07 |
Efficacy of VALERGEN-DS subcutaneous vaccine in asthmatic adults. |
BIOCEN |
Registered |
2010-12-08 |
Efficacy of VALERGEN-BT sublingual vaccine in asthmatic adults. |
BIOCEN |
Registered |
2010-12-08 |
Efficacy of VALERGEN-DS sublingual vaccine in asthmatic adults |
BIOCEN |
Registered |
2010-12-09 |
Evidence of the clinical efficacy of VALERGEN-DS vaccine in asthmatics. |
BIOCEN |
Registered |
2010-12-09 |
Evidence of the clinical efficacy of VALERGEN-BT vaccine in asthmatics |
BIOCEN |
Registered |
2010-12-09 |
Efficacy of VALERGEN-DP sublingual vaccine in asthmatic adults. |
BIOCEN |
Registered |
2010-12-09 |
Evidence of the clinical efficacy of VALERGEN-DP vaccine in asthmatics |
BIOCEN |
Registered |
05/05/2020 |
Biomodulina T - IM- covid-19 - older adultos - Phase IV clinical trial |
BIOCEN |
Registered |